[xoo_el_inline_form active="login"]

Dall·e 2024 07 15 00.54.48 A Futuristic Laboratory Setting Where Scientists Are Working With High Tech Equipment And T Cells. The Focal Point Is A Group Of Scientists In White L

賽昂生醫授權 CD19 Armed-T 細胞進行血癌藥物開發與追日潤公司合作

Date: March 19, 2024
Innovative Partnership for Advanced Cancer Therapy
For more details, visit CTEE News.

SL-LINK Company has secured a license from CytoArm to develop the Armed-T cell therapy that targets blood cancers such as leukemia and multiple myeloma.

CD-19 is a B cell surface antigen that is expressed during the early stages of B cell development and continues to be present through the cell’s lifespan. It is absent in most other cell types, making it an ideal target for therapies aimed at B cell malignancies. These cancers include:

  1. Acute Lymphoblastic Leukemia (ALL): A type of cancer that affects the blood and bone marrow, ALL is particularly aggressive and common in children.
  2. Chronic Lymphocytic Leukemia (CLL): A slower-growing cancer of the blood and bone marrow that typically affects older adults.
  3. Diffuse Large B-Cell Lymphoma (DLBCL): The most common type of non-Hodgkin lymphoma, characterized by rapidly growing tumors in the lymph nodes, spleen, liver, bone marrow, or other organs.
  4. Follicular Lymphoma: A generally slow-growing type of non-Hodgkin lymphoma that arises from B cells.

The Role of CD-19 in Cancer Therapy

The expression of CD-19 on B cells and its critical role in the pathogenesis of B-cell malignancies make it an attractive target for cancer therapy. Traditional treatments such as chemotherapy and radiation therapy, while effective to a degree, often come with significant side effects and are not always successful in eradicating the disease. This has led to the development of more targeted approaches, including CD-19 Armed-T cell therapy.

The benefits of CD-19 Armed-T cell therapy are targeting patients who have exhausted all other treatment options. Ongoing development aims to improve the safety and efficacy of this treatment, making it more accessible and affordable.

zh_TWChinese